• 1
    Thiele EA. Assessing the efficacy of antiepileptic treatments: the ketogenic diet. Epilepsia 2003;44(suppl 7):S269.
  • 2
    Freeman JM, Vining EPG, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet, 1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998;102: 135863.
  • 3
    Hemingway C, Freeman JM, Pillas DJ, Pyzik PL. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 2001;108: 898905.
  • 4
    Kinsman SL, Vining EPG, Quaskey SA, Mellits D, Freeman JM. Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 1992;33: 11326.
  • 5
    Wheless JW. The ketogenic diet: an effective medical therapy with side effects. J Child Neurol 2001;16: 6335.
  • 6
    Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004;45: 111623.
  • 7
    Ballaban-Gil K, Callahan C, O'Dell C, Pappo M, Moshé S, Shinnar S. Complications of the ketogenic diet. Epilepsia 1998;39: 7448.
  • 8
    Rios VG. Complications of treatment of epilepsy by a ketogenic diet. Rev Neurol 2001;33: 90915.
  • 9
    Product Information, Depakote®, Depakene®, Abbott Laboratories, Inc., Physicians Desk Reference, Thomson PDR, Montvale , NJ , 2005.
  • 10
    LevyRH, MatsonRH, MeldrumBS, PeruccaE, eds. Antiepileptic drugs, 5th ed. Philadelphia : Lippincott Williams & Wilkins, 2002.
  • 11
    De Vivo DC, Bohin TP, Coulter DL, et al. l-carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia 1998;39: 121625.
  • 12
    Kwiterovich PO Jr, Vining EPG, Pyzik P, Skolasky R Jr, Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003;290: 91220.
  • 13
    Delgado MR, Mills J, Sparagana S. Hypercholesterolemia associated with the ketogenic diet. Epilepsia 1996;37(suppl 5):108.
  • 14
    Livingstone S, Pauli LL, Pruce I. Ketogenic diet in the treatment of childhood epilepsy. Dev Med Child Neurol 1977;19: 8334.
  • 15
    Bryant AE, Dreifuss FE. Valproic acid hepatic fatalities. III. US experience since 1986. Neurology 1996;46: 4659.
  • 16
    Buse GJ, Riley KD, Dress CM, Neumaster TD. Patient with gemfibrozil-controlled hypertriglyceridemia that developed acute pancreatitis after starting ketogenic diet. Curr Surg 2004;61(2):2246.
  • 17
    Stewart WA, Gordon K, Camfield P. Acute pancreatitis causing death in a child on the ketogenic diet. J Child Neurol 2001;16(9):682.
  • 18
    Chapman SA, Wachsman GP, Patterson BD. Pancreatitis associated with valproic acid: a review of the literature. Pharmacotherapy 2001;21(12):154960.
  • 19
    Asconapé JJ, Penry JK, Dreifuss FE, et al. Valproate associated pancreatitis. Epilepsia 1993;34: 17783.
  • 20
    Knorr M, Schaper J, Harjes M, Mayatepek E, Rosenbaum T. Fanc–71.
  • 21
    Lande MB, Kim MS, Bartlett C, Guay-Woodford LM. Reversible Fanconi syndrome associated with valproate therapy. J Pediatr 1993;123: 3202.
  • 22
    Lenoir GR, Perignon JL, Broyer M. Valproic acid: a possible cause of proximal tubular renal syndrome. J Pediatr 1981;98: 5034.
  • 23
    Jeavons PM. Non-dose related side effects of valproate. Epilepsia 1984;25(suppl 1):S505.
  • 24
    Coulter DL. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity (letter). Lancet 1984;323(8378):689.
  • 25
    Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, Menander KB. Valproic acid hepatic fatalities: a retrospective review. Neurology 1987;37: 37985.
  • 26
    Ater SB, Benefield WH, Saklad JJ, Saklad SR. A developmental center population treated with VPA and L-carnitine. In: Update 1993: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals, 1993.
  • 27
    Coulter DL, Wu H, Allen RJ. Valproic acid therapy in childhood epilepsy. JAMA 1980;244: 7858.
  • 28
    Berry-Kravis E, Booth G, Sanchez AC, Woodbury-Kolb J. Carnitine levels and the ketogenic diet. Epilepsia 2001;42: 144551.
  • 29
    Hirose S, Mitsudome A, Yasumoto S, Ogawa A, Muta Y, Tomoda Y. Valproate therapy does not deplete carnitine levels in otherwise healthy children. Pediatrics 1998;101(5):E9.
  • 30
    Fung EL, Tang NL, Ho CS, Lam CW, Fok TF. Carnitine level in Chinese epileptic patients taking sodium valproate. Pediatr Neurol 2003;28: 247.
  • 31
    Bohan TP, Helton E, McDonald I, et al. Effect of l-carnitine treatment for valproate-induced hepatotoxicity (brief communication). Neurology 2001;56: 14059.